Liver News and Research

RSS

Researchers re-invented class of popular antimicrobial drugs by altering their chemical structures

By tinkering with their chemical structures, researchers at the University of California, San Diego School of Medicine have essentially re-invented a class of popular antimicrobial drugs, restoring and in some cases, expanding or improving, their effectiveness against drug-resistant pathogens in animal models.

8 Oct 2013

Vaccination campaign led HBV to more than double rate of "breakout" mutations

A universal infant vaccination campaign in China has led the Hepatitis B virus (HBV) to more than double its rate of "breakout" mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination strategies.

8 Oct 2013

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.

7 Oct 2013

New injection device delivers optimum treatment dose to hepatitis C patients

A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).

5 Oct 2013

Viewpoints: Marketplaces offer Americans the kind of shopping they like; enrollment isn't as robust as administration claims

Americans have grown accustomed to online comparison shopping, as the overwhelming number who clicked on health-exchange websites demonstrates.

5 Oct 2013

FDA approves Clinolipid injectable emulsion for intravenous feeding in adult patients

The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink. Clinolipid was granted a priority review to help alleviate a drug shortage.

5 Oct 2013

New biomarker for pancreatic cancer effectively targets potential therapy for small survival rate

University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.

5 Oct 2013

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

5 Oct 2013

Cholesterol-lowering drugs could be alternative treatment for people who take statins

A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique’s feasibility and safety.

4 Oct 2013

Substance abuse treatment before, after liver transplantation has lower alcohol relapse rates

New research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates than those untreated or only treated prior to transplantation.

4 Oct 2013

Diet high in certain type of fat may actually increase metabolism

A diet high in a certain type of fat may actually increase metabolism, according to recent research by Texas Tech University nutrition scientists.

3 Oct 2013

New agreement to expand scope of research project to evaluate MCT-485 for primary liver cancer

MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.

2 Oct 2013

Saint Luke's liver transplantation program receives CMS certification

The liver transplantation program at Saint Luke's Hospital of Kansas City has received certification by the Centers for Medicare and Medicaid. The certification is an important step in enhancing the hospital's ability to care for Medicare-covered patients suffering from end-stage liver disease, and attract other insurers who base their coverage on the CMS certification.

2 Oct 2013

Genetic discovery could take guesswork out of prescribing correct dose of drugs

The discovery of genetic differences affecting up to a third of the population could take the guesswork out of prescribing the correct dose of 25 percent of drugs currently on the market, researchers say.

2 Oct 2013

Researchers develop renal risk index to predict post-transplant end-stage renal disease

End-stage renal disease is one of the major public health problems among solid organ transplant recipients that is associated with death after transplant and high cost of care.

2 Oct 2013

Genetic study helps identify obese diabetes patients who are at risk of developing NAFLD

A groundbreaking study of nearly 2,300 extremely obese diabetes patients, led by the Translational Genomics Research Institute, has identified genes associated with unhealthy liver function.

2 Oct 2013

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

New data from Boehringer Ingelheim's hepatitis C virus clinical development program have been accepted for presentation at the 64th Annual Meeting of the American Association for the Study of Liver Diseases, also known as The Liver Meeting®, taking place November 1-5 in Washington, D.C.

1 Oct 2013

Life-prolonging effect of vitamin niacin demonstrated in roundworms

Who would not want to live a long and healthy life? A freely available food supplement could help in this respect, scientists from ETH Zurich have demonstrated in roundworms. Vitamin B3 - also known as niacin - and its metabolite nicotinamide in the worms' diet caused them to live for about one tenth longer than usual.

1 Oct 2013

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Canada should begin screening 'Baby Boomers' for the hepatitis C virus infection, since this age group is likely the largest group to have the illness, and most don't know they have it, say a group of liver specialists in the Toronto Western Hospital Francis Family Liver Clinic. Unlike many other chronic viral infections, early treatment makes hepatitis C curable.

1 Oct 2013

Report: More Hispanic Texans die from cancer than any other cause

More Hispanic Texans die from cancer than any other cause, according to a new report by the Comparative Effectiveness Research on Cancer in Texas research group.

1 Oct 2013

Liver News and Research

Researchers re-invented class of popular antimicrobial drugs by altering their chemical structures

Vaccination campaign led HBV to more than double rate of "breakout" mutations

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

New injection device delivers optimum treatment dose to hepatitis C patients

Viewpoints: Marketplaces offer Americans the kind of shopping they like; enrollment isn't as robust as administration claims

FDA approves Clinolipid injectable emulsion for intravenous feeding in adult patients

New biomarker for pancreatic cancer effectively targets potential therapy for small survival rate

New technique for breast cancer treatment and prevention-injection via nipple

Cholesterol-lowering drugs could be alternative treatment for people who take statins

Substance abuse treatment before, after liver transplantation has lower alcohol relapse rates

Diet high in certain type of fat may actually increase metabolism

New agreement to expand scope of research project to evaluate MCT-485 for primary liver cancer

Saint Luke's liver transplantation program receives CMS certification

Genetic discovery could take guesswork out of prescribing correct dose of drugs

Researchers develop renal risk index to predict post-transplant end-stage renal disease

Genetic study helps identify obese diabetes patients who are at risk of developing NAFLD

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

Life-prolonging effect of vitamin niacin demonstrated in roundworms

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Report: More Hispanic Texans die from cancer than any other cause

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News